TrialHaematologica2019

A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma.

Rémy Gressin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.